Team

Michael Chermak has 40 years of experience in leadership roles in the healthcare industry and has raised over $200 million for his various enterprises, both private and public. Michael is the founder of Makena Investment Advisors, LLC., a firm focused on assisting emerging companies access equity capital markets. He currently serves as an officer and/or director for a few select public and private entities. Previously, he was the founder and CEO of Healthdemographics, Inc., a company in the healthcare predictive data and decision support business, with over 1,200 clients worldwide and was regularly sourced by the Wall Street Journal for articles on the healthcare industry. He sold the company in 1997 to Medirisk.
In 1998, he was the co-founder, initial investor, and original Chairman of Medibuy.com, an Internet healthcare supply vendor. Medibuy raised over $140 million in its first 18 months of operation backed by leading VCs such as Kleiner Perkins, Sequoia, Oak, and institutional investors including Alianz. Medibuy acquired the ecommerce initiatives of two leading GPOs, Premier and Columbia HCA, that at one time accounted for nearly 70% of healthcare product expenditures in the US. Medibuy was sold to GHX (Global Health Exchange), an ecommerce company founded by General Electric, Abbot, Baxter, Medtronic. Becton-Dickinson, Braun, Guidant, Tyco, Siemens, and others.

He worked in China for over 6 years and was the former Chairman and CEO of Bridgetech Holdings International (OTC: BGTH), which focused on introducing Western medicine into China. He has served on the Board of Directors and as an Audit Committee member of Beijing Origin Seed (NASDAQ: SEED), a Chardan Capital SPAC.

Michael graduated from the University of New Mexico, Anderson School of Management. Michael and his wife fund and run a 501c3 animal sanctuary and are focused on animal rescue and the support of rescue organizations.

Ian Subel has been nominated to serve as an independent member of our board of directors commencing as of the effective date of the registration statement. Ian is currently Managing Director of Fogel Capital Partners (2011 –Present), providing corporate finance advisory services through numerous Family Office and other organizations in, amongst others, the renewable energy, insurance, consumer products, healthcare, technology, oil and gas sectors. Mr. Subel was a Managing Director at Deloitte Corporate Finance, LLP from February 1998 to February 2002 and became a Partner during his five-year tenure at Fisher Hoffman Sithole/Panell Kerr Forester (1992 – 1997).

Ian has extensive executive experience leading wealth management firms. Ian graduated from the University of the Witwatersrand in South Africa with both a Bachelor of Commerce and a Bachelor of Accounting and holds a CPA and several insurance licenses.

Doug Cole has been nominated to serve as an independent member of our board of directors commencing as of the registration statement’s effective date. From November 2017 to August 2021, Mr. Cole was the Chairman and Chief Executive Officer of American Battery Metals Corporation (OTCQB:ABML) and led the transition from a lithium exploration and development company to a lithium asset and lithium-ion battery metal recycling company.
Doug has been a Partner with Objective Equity LLC since January 2005, a boutique investment bank focused on the high technology, data analytics, and the mining sector, overseeing all ongoing deal activities.

Doug received his bachelor’s degree in Social Sciences from the University of California, Berkeley.